Lots of buzz beginning for TRON. Let the noise bring the

New Post Public Reply Private Reply Replies (1) Message Board
Mysterium
963
Lots of buzz beginning for TRON. Let the noise bring the eyes and ears to the ticker. Experienced traders and board users will sift through the dialogue and determine what is what. They also know which people are honest and which are there to rattle the cages. No one posts for the bulls or the bears without a position that they have taken(or will take) for financial gain. Know the players, know the motives.

Covering other ground, while it would have been nice to have had more ongoing dialogue from Rene, the lack of updates during his tenure were diametrically opposite from someone who was pumping and/or diluting a stock. The chances of it being a scam are very slim when shares aren't flooding the market in tandem with multiple, closely-spaced press releases that have no items seen through to closure. In the case here, the deal was seen through from start to finish, with investors now just waiting on SEC/legal filings.

The InMed acquisition was announced, then came the funding, then funding switched from Continental as the lender to Flagship, the closing of the deal was announced, letters by CEO of InMed and Flagship confirmed the closing and the funding, shares were transferred, InMed entities dissolved on the same date as mentioned by InMed CEO within the Toron press release, and then announcement of further funding and expansion of scope and acquisition began. 8k and audits to come, with intent to uplist. No parties have denied any public communications posted by Toron. The only retraction was by Toron, and was regarding the fake PR, however the closing of the deal that was alluded to in the fake PR actually took place shortly thereafter.

Also, keep in mind that insider ownership is in the form of common shares, not restricted, and not preferred. This means that insiders and retail holders are in the same boat.

By the numbers, Pantheon owns 200M, Patienttrac has another 81M, and InMed and Flagship each have 100M per party. In total, that is 481M shares, with 400M being restricted. With the inclusion of Patienttrac's 81M, the float is 380M, so by obvious definition, if 200-400M were being dumped into the market, and many days the price drops 10-12 ticks off of 1M or less in volume, then the sale of 100M or more shares would drop this thing to the floor, seeing as the restricted shares would more than double the float. The price would not hold, nor would volume remain low in the presence of a doubling of the available floating shares. Not only would retail have to hold and not sell, but buying pressure would have to be so strong and continuous that the share price didn't waver. We're not seeing anything like that. People are waiting on filings, and in the meantime, a few shares are getting sold and a few are getting bought. Plus, why would any of the four entities holding crush the stock? Any one party that did that would destroy the holdings of the other three they are in business with. If they suspected that, then either legal teams would be on this immediately on behalf on the holders and/or the other parties would race to liquidate while they could, with retail shareholders doing the same. That's just not happening. Additionally, dumping a large holding without any kind of public marketing campaign would just mean that the person unloading would get less and less for each lot of shares sold, seeing as that type of unloading would tank the price. Unless it was a short seller who was driving it down to begin covering and buying for the next uptrend to trade, one would be shooting themselves in the foot. More on that in a minute....

Emotionally speaking, some are comfortable with Rene's departure, and some are not. But either way, the facts are not all on the table yet. Pantheon is still in this, holding 200M, and Rene still owns Pantheon, so he's not gone, even if his name tag has a different title. There could have been any number of reasons for stepping down, ranging from a) legal advisement, seeing as he may need to be a bit more removed, and owning Pantheon without operating Toron would create legal breathing room for Pantheon, b) taxing and financial decisions for efficiency, profitability or legality, c) personal issues or health issues, d) outside business issues, e) insider business issues, such as conflict of interest between Pantheon, Toron, InMed etc and the holding of owner-operator-director status of more than one simultaneously, f) board decision, including his, that someone with a medical background would be the most effective. And as a wild card, g) there is always the chance he could step back in as CEO at a later date, with the Interim CEO only there to fill the gap, but with the interim changes needing to be formally filed if required by the legal team.


There does not seem to be any irrefutable evidence of a scam. Could it happen? Sure. There could always be a backdoor avenue, such as an insurance racket by which the hospitals are being used - but that is such a far stretch of the imagination that it holds zero merit and is just a conjuring up of possibilities.

The best DD has come from hospital numbers, onsite visits, paperwork showing dissolution, people speaking with parties related to InMed or Toron, proper press releases, filings, letters, etc. No other DD is coming close. And it destroys the credibility of the counter party when people are smeared before they are even properly identified. If they'll do that, they'll smear anyone, for any and no reason at all. And if someone is a friend of someone, that proves nothing. That would be like saying that if a friend or business relation once had an affair, then you were not a trustworthy partner either. Kind of like the cliched saying about height and doctors. If most doctors are tall, does that automatically mean most tall people are doctors?


As something of additional note, take a look at this post from the other day(from elsewhere):

"Here my guess as to what will happen over the next 90 days:

Rene’s departure is part of a strategy to cash out for him and Wayne

They will drive the price up, and sell into the price increase, and then cover when the paper becomes free trading."




That seems like the shorts are telegraphing their moves.

Look at the last line. Why would Rene have to cover? Do you or I have to cover if we are not shorting?

I mentioned that in the link below, guessing that that was what was being done to some degree:

https://investorshangout.com/post/view?id=5324066

Pretty interesting. Hope you are loading, shorts! This would be an ideal place to cover should there still be any risk involved via the sake of an 8k and an uptrend - unless some of those free shares are being held with an iron grip to try to create a selloff on the filing of the 8k so as to drop the price and cover. Whatever the case, once the numbers are out, the book value changes and in time, that will be accurately reflected in the price per share of stock.


Long story short, yes, we need updates, but aside from the need for communication - which was an issue in between each stage of the InMed deal(LOI, funding, change in funding, closing) - nothing is really raising eyebrows, good or bad, in the meantime. We're in a bit of quiet period until the filings begin hitting once the board is legally depicted as in place.


And for something fun to take everyone into the weekend. SHMP was at .006 in November, much like where TRON is to date, and is now in the .60's as of typing this. TRON can get there too and that would put this on the map, seeing as we are still very much an under-the-radar stock.

Hope everyone is doing well and made through the polar vortex alright. Enjoy the day! Good things are coming!



SHMP chart:

https://stockcharts.com/h-sc/ui?s=shmp




$TRON for the win in 2019, 2020 and beyond!

ALL THINGS MOBILE ANALYTIC INC. (ATMH) Stock Research Links

ATMH Board Company Profile Buy Rating Time & Sales News Filings Financials
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Matthew Callstrom Named CEO: Mayo Clinic's Next Era

Updated Category News Views 192

Leadership Change at Mayo Clinic: A Turning Point The Mayo Clinic, a titan in healthcare lands, is on the cusp of a major leadership switch-up. As the trustees hand the reins to Dr. Matthew R. Callstrom, they're banking on a rich blend of experience and visionary thinking to steer their ship. We're looking at what this change might spell for Mayo's storied mission. Who is...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 174

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 196

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 145

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Enjay Acquires New Method: A Strategic Synergy Unfolds

Updated Category News Views 116

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Continue Reading
Paris Baguette Opens New Café in Novato, CA

Updated Category News Views 115

Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 144

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
HNTB Partners with Kansas City Chiefs for New Stadium

Updated Category News Views 118

A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 183

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading

Top 5 Most Recently Viewed Articles

Comprehensive Overview of Share and Voting Rights Data

Updated Category News Views 243

Monthly Declaration of Lectra's Shares and Voting Rights Every month, companies are required to report their share and voting rights status, providing crucial transparency for investors and stakeholders. One such monthly declaration was made by Lectra, outlining the comprehensive details about the total number of shares and voting rights as of a recent date. Understanding...

Continue Reading
Generate Capital Welcomes Paul Ross as New Investor Solutions Leader

Updated Category News Views 508

Generate Capital Strengthens Team with New Appointment Generate Capital, PBC, a trailblazer in sustainable infrastructure investments, has enhanced its Capital Formation team with the appointment of Paul Ross as Global Head of Investor Solutions. This strategic move signifies the company’s commitment to expanding its engagement with institutional and private investors....

Continue Reading
HDF and IOM Join Forces for Crisis Relief Efforts

Updated Category News Views 159

New Partnership Navigates Humanitarian Complexities Alright, let's cut to the chase. Today, HDF and IOM threw another log on the fire powering humanitarian aid. These big names just inked a Memorandum of Understanding in Geneva, emphasizing their goal of streamlined cooperation to counter crises in Sudan and Yemen. Now, if you're curious about the weight of such...

Continue Reading
Red Violet's Strategic Presence at IDEAS Investor Conference

Updated Category News Views 155

Red Violet to Present at Key Investor Conference BOCA RATON, Fla. — Red Violet, Inc. (NASDAQ: RDVT), recognized as a leader in analytics and information solutions, has announced its participation in the upcoming East Coast IDEAS Investor Conference. This significant event is scheduled to take place on June 11-12, bringing together influential investors and industry...

Continue Reading
Exciting Future: Sonnet BioTherapeutics and Hyperliquid Unite

Updated Category News Views 151

Exciting Development for Sonnet BioTherapeutics Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) has reached a significant milestone by receiving stockholder approval for its proposed business combination with Hyperliquid Strategies Inc. This exciting news comes from a special meeting held recently where stockholders voted on vital initiatives aimed at driving the...

Continue Reading